William R. Wilson

Mechanism of Action and Preclinical Antitumor Activity of the Novel Hypoxia-Activated DNA Cross-Linking Agent PR-104

Adam V. Patterson, Dianne M. Ferry, Shelley J. Edmunds et al. · Clinical Cancer Research · 2007 · 243 citations · Full text

Introducing OCTAVE Allegro: Improving the Information Security Risk Assessment Process

Richard A. Caralli, James F. Stevens, Lisa R. Young et al. · Figshare · 2007 · 204 citations · Full text

Engineering, Information Security, Octave Methods +24

A semiautomated microculture method for investigating growth inhibitory effects of cytotoxic compounds on exponentially growing carcinoma cells

Graeme J. Finlay, Bruce C. Baguley, William R. Wilson · Analytical Biochemistry · 1984 · 200 citations

Oncology, Chemoprevention Strategy, Carcinoma Cells +12

The Bioreductive Prodrug PR-104A Is Activated under Aerobic Conditions by Human Aldo-Keto Reductase 1C3

Christopher P. Guise, Maria R. Abbattista, Rachelle S. Singleton et al. · Cancer Research · 2010 · 185 citations · Full text

Cancer Metabolism, Reductive Stress, Tumor Hypoxia +15

Viral and Epidemiologic Studies of Idiopathic Sudden Hearing Loss

William R. Wilson, Robert W. Veltri, Nan M. Laird et al. · Otolaryngology · 1983 · 173 citations